NewBiologix
Entity

  • NewBiologix

    Created in 2023
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,557

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    Rte de la Corniche 6/building 1066, 1066 Epalinges, Switzerland

    Epalinges

    Switzerland

  • Employees

    Scale: 2-10

    Estimated: 20

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year ago
Description
  • Value proposition

    Developing technologies for the biopharma industry to allow them
    to treat the root causes of diseases and disorders.

    Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.

    gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines

  • New Biologix - Gene therapy for everyone, made possible.

    Engineered cell line technology that produces safe and effective AAV drugs for gene therapy, making treatments more affordable and accessible.

    • https://www.newbiologix.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics